新青年麻醉论坛

 找回密码
 会员注册

QQ登录

只需一步,快速开始

快捷登录

搜索
热搜: 麻醉 视频 中级
查看: 3931|回复: 1
打印 上一主题 下一主题

[English Forum] 澳纽专科考题2--ANZCA exam question & answer

[复制链接]
跳转到指定楼层
1#
发表于 2009-12-11 12:01:44 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
本帖最后由 shenxiu2 于 2009-12-11 12:08 编辑

2000A:2




Justify the measures you would use to minimise the risk of acute tubular
necrosis if the surgeon is to clamp the supra-renal aorta in Abdominal aortic aneurysm surgery.


楼主热帖

马上注册,享用更多功能,让你轻松玩转论坛

您需要 登录 才可以下载或查看,没有帐号?会员注册

x

 友情提示:论坛资源下载与分享的详细说明  (←点击查看详情

2#
 楼主| 发表于 2009-12-17 14:15:53 | 只看该作者
本帖最后由 shenxiu2 于 2009-12-17 14:17 编辑

Renal dysfunction is a result of hypoperfusion and renal ischaemia during the period of cross-clamping. The most dangerous complication of alteration of renal blood flow is ATN and subsequent ARF.

ARF after aortic aneurysm repair is associated with a mortality of >40%. Decreased renal function is observed in many patients after aortic cross-clamping (even when the clamp is place distal to the renal arteries).

There are a number of physiological and pharmacological method that can be used to minimize the risk of ATN.

Prior to Aortic Clamping.
-Potential damage to the kidneys can be limited by avoiding a prerenal injury before clamp placement. Volume resuscitation (crystalloid/colloid), with maintenance of cardiac output and adequate circulating blood volume are the best way to accomplish this goal.

-Various pharmacological manipulations are begun in anticipation of the aortic cross-clamp:


->Dopamine (1-3micrograms/Kg/min) increases renal blood flow and improves urine output. Decreased incidence in preventing post-op ATN/ARF not proven however.



->Mannitol (0.25g/Kg) attenuates the reduction of renal cortical blood flow before, during and after renal ischaemia and causes concurrent increase in GFR. May also act as a scavenger of free radicals, decrease rennin secretion and increase renal prostaglandin secretion.



->Frusemide (up to 1mg/Kg) may also improve urine output. Care to avoid hypovolaemia and hypokalaemia.


(Strong clinical evidence is currently lacking, although experimental evidence tends to support these pharmacological practices.)

During Cross-Clamping.
-Maintenance of adequate circulating blood volume remains the mainstay. Compensating for volume loss with crystalloid, colloid or blood products as appropriate.

-Use of cold renal perfusate induces renal hypothermia and allows the kidneys to tolerate longer periods of hypoperfusion.

-The most direct approach is to provide perfusion to the renal arteries while the cross-clamp is on. Selective renal perfusion (ie.small catheters used to cannulate the renal arteries with blood flow being diverted from the upper aorta) and distal aortic perfusion (ie. CPB or Left atrial-left femoral artery bypass) are techniques employed for renal protection from ischaemia.

Post Cross-Clamping.
-Anticipate declamping shock, which be another late yet significant insult to renal
perfusion. Hypervolaemia and systolic hypertension are short term goals that must be achieved just prior to removal of the cross-clamp.


-Volume resuscitation if hypotensive with crystalloid or colloid.

-Pharmacologically, temporary ionotropic support to maintain blood pressure and cardiac output.


REF. Yao & Artusio 5th edn; pp. 297, 302-303, 308, 330.

Miller 5th edn; p. 1865.

活动公告:做任务得积分和权限(新手奖励计划) (←点击查看详情)

您需要登录后才可以回帖 登录 | 会员注册

本版积分规则

收藏帖子 返回列表 联系我们 搜索 官方QQ群

QQ|关于我们|业务合作|手机版|新青年麻醉论坛 ( 浙ICP备19050841号-1 )

GMT+8, 2025-2-3 04:07 , Processed in 0.141540 second(s), 26 queries , Gzip On.

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表